There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Aris Perperogou |
| Institution: | GSK |
| Department: | Predictive Modelling |
| Country: | |
| Proposed Analysis: | The ADNI dataset will be used to inform and support translational and precision medicine strategies for key molecular targets. Specifically, we are interested in identifying patient sub-groups that are more likely to benefit from potential treatment interventions. This will be achieved by longitudinal, cross-sectional and correlative analyses that are typically used in patient stratification. Additionally, efforts will be made to identify novel disease and surrogate biomarkers that are associated with key clinical covariates. |
| Additional Investigators | |
| Investigator's Name: | Tom Taverner |
| Proposed Analysis: | Assist primary investigator with statistical analysis |
| Investigator's Name: | Doug Thompson |
| Proposed Analysis: | Assist primary investigator with statistical analysis |
| Investigator's Name: | Dave Lunn |
| Proposed Analysis: | Assist primary investigator with statistical analysis |
| Investigator's Name: | Paul Newcombe |
| Proposed Analysis: | Assist primary investigator with statistical analysis |
| Investigator's Name: | Ashwini Venkatasubramaniam |
| Proposed Analysis: | Assist primary investigator with statistical analysis |
